Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-31 @ 11:10 AM
Study NCT ID:
NCT01968460
Status:
COMPLETED
Last Update Posted:
2023-04-07
First Post:
2013-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease
Sponsor:
Pharma Two B Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12
Start Date Type:
None
Primary Completion Date:
2015-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-15
First Submit QC Date:
None
Study First Post Date:
2013-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-10-31
Results First Submit QC Date:
None
Results First Post Date:
2023-04-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-15
Last Update Post Date:
2023-04-07
Last Update Post Date Type:
ACTUAL